SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

BINNS ROBERT HUGH

(Last)

(First)

(Middle)

C/O HP INC.

1501 PAGE MILL ROAD

(Street)

PALO ALTO

94304

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2015

3. Issuer Name and Ticker or Trading Symbol
HP INC [ HPQ ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	HGT and IR, Treasurer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	23,410	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (right to buy)	05/22/2007⁽¹⁾	05/22/2016⁽³⁾	Common Stock	1,212	$25.1	D
Employee Stock Option (right to buy)	09/27/2012⁽¹⁾	09/27/2019⁽³⁾	Common Stock	4,610	$23.59	D
Employee Stock Option (right to buy)	12/07/2012⁽¹⁾	12/07/2019⁽³⁾	Common Stock	2,436	$28.41	D
Employee Stock Option (right to buy)	04/23/2013⁽¹⁾	04/23/2020⁽³⁾	Common Stock	4,500	$24.27	D
Employee Stock Option (right to buy)	12/06/2013⁽¹⁾	12/06/2020⁽³⁾	Common Stock	5,625	$13.83	D
Employee Stock Option (right to buy)	12/11/2014⁽¹⁾	12/11/2021⁽³⁾	Common Stock	6,000	$26.99	D
Employee Stock Option (right to buy)	09/17/2015⁽¹⁾	12/10/2022⁽³⁾	Common Stock	7,500	$37.36	D
Employee Stock Option (right to buy)	10/30/2016⁽²⁾	10/30/2023⁽³⁾	Common Stock	41,733	$26.96	D
Restricted Stock Units	⁽⁴⁾⁽⁶⁾	⁽⁶⁾	Common Stock	2,079.5669	⁽⁵⁾	D
Restricted Stock Units	⁽⁷⁾	⁽⁷⁾	Common Stock	9,949.8868	⁽⁵⁾	D
Restricted Stock Units	⁽⁸⁾	⁽⁸⁾	Common Stock	2,394.1251	⁽⁵⁾	D
Restricted Stock Units	⁽⁴⁾⁽⁹⁾	⁽⁹⁾	Common Stock	5,105.4174	⁽⁵⁾	D
Restricted Stock Units	⁽¹⁰⁾	⁽¹⁰⁾	Common Stock	13,909	⁽⁵⁾	D

Explanation of Responses:

1. This option became exercisable beginning on this date.

2. This option will become exercisable in three equal annual installments beginning on this date.

3. This option is no longer exercisable beginning on this date.

4. On 07/29/15 the Issuer announced approved amendments to certain outstanding long-term incentive awards that were originally scheduled to vest between 09/18/15 and 12/31/15, to provide for the accelerated vesting on 09/17/15.

5. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

6. On 12/11/13 the reporting person was granted 6,000 restricted stock units ("RSUs"), 2,000 of which vested on 12/11/14, 2,000 of which vested early on 09/17/15, and 2,000 of which will vest on 12/11/16. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 79.5669 vested dividend equivalent rights accrued but not released since the grant date.

7. On 06/16/14 the reporting person was granted 14,550 RSUs, 4,850 of which vested on 06/16/15, and 4,850 of which will vest on each of 06/16/16 and 06/16/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 249.8868 vested dividend equivalent rights accrued but not released since the grant date.

8. On 06/16/14 the reporting person was granted 3,500 RSUs, 1,166 of which vested on 06/16/15, and 1,167 of which will vest on each of 06/16/16 and 06/16/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 60.1251 vested dividend equivalent rights accrued but not released since the grant date.

9. On 12/10/14 the reporting person was granted 7,500 RSUs, 2,500 of which vested early on 09/17/15, and 2,500 of which will vest on each of 12/10/16 and 12/10/17. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock. The number of derivative securities in column 5 includes 105.4174 vested dividend equivalent rights accrued but not released since the grant date.

10. On 10/30/15 the reporting person was granted 13,909 RSUs, 4,636 of which will vest on each of 10/30/16 and 10/30/17, and 4,637 of which will vest on 10/30/18. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on the Issuer's common stock.

Remarks:

	Katie Colendich as Attorney-in-Fact for Robert H. Binns	11/12/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.